Loading market data...
Thursday, August 27, 2026
Back to HomeStock AnalysisPremiumAll Altria Group coverage

Altria (MO) Q2 2026: Oral Tobacco Underlying Profit Falls 8% to $459M; Reported 24% Drop Driven by Relocation Charge

Share
Altria (MO) Q2 2026: Oral Tobacco Underlying Profit Falls 8% to $459M; Reported 24% Drop Driven by Relocation Charge

Altria (MO) Q2 2026: Oral Tobacco Underlying Profit Falls 8% to $459M; Reported 24% Drop Driven by Relocation Charge

Altria's cigarette business is still winning the price-versus-volume fight. Revenue net of excise taxes rose 1.2% in the second quarter, to $5.36 billion from $5.29 billion. But reported second-quarter operating income fell 2.9% to $3.14 billion, and the damage came almost entirely from the one business that was supposed to be growing: oral tobacco, where segment profit dropped 23.5% to $381 million. Most of that drop is a factory-relocation charge rather than a collapse in the underlying business, which makes the quarter look worse than it was — and makes the shrinking top line of the smoke-free franchise the more important signal.


1. Balance Sheet: Cash Halves, Debt Falls, Deficit Narrows

1-1. Major Asset Items

ItemDec 31, 2025 ($M)Jun 30, 2026 ($M)Change %
Cash and cash equivalents4,4742,367-47.1%
Receivables263306+16.3%
Inventories1,0701,060-0.9%
Property, plant and equipment, net1,7101,757+2.7%
Goodwill5,7875,7870.0%
Other intangible assets, net11,87611,850-0.2%
Investments in equity securities8,6178,896+3.2%
Total assets35,01733,374-4.7%

The $2.11 billion cash drawdown is the headline movement, and it is deliberate rather than distressed. Altria repaid $1.1 billion of debt, paid $3.56 billion in dividends, and bought back $335 million of stock — all without issuing a single dollar of new debt, versus $997 million issued a year earlier.

Inventories were essentially flat, but the mix shifted. Leaf tobacco fell to $420 million from $531 million while finished product rose to $345 million from $281 million — a working-capital pattern consistent with drawing down raw material rather than building unsold stock.

Unlimited U.S.-market analysis, $9.99/month

Altria (MO) Q2 2026: Oral Tobacco Underlying Profit Falls 8% to $459M; Reported 24% Drop Driven by Relocation Charge

This article became available on August 27, 2026. Subscribe to read in full, or wait until November 25, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

Access is tied to your account. Subscribe with the same email you sign up with — if you already paid, sign up with that email and it unlocks automatically.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →
This company

Full report on Altria Group

We read Altria Group's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the Altria Group report
Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.